Literature DB >> 17558391

'Rejuvenation' protects neurons in mouse models of Parkinson's disease.

C Savio Chan1, Jaime N Guzman, Ema Ilijic, Jeff N Mercer, Caroline Rick, Tatiana Tkatch, Gloria E Meredith, D James Surmeier.   

Abstract

Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual reliance of these neurons on L-type Ca(v)1.3 Ca2+ channels to drive their maintained, rhythmic pacemaking renders them vulnerable to stressors thought to contribute to disease progression. The reliance on these channels increases with age, as juvenile dopamine-containing neurons in the substantia nigra pars compacta use pacemaking mechanisms common to neurons not affected in Parkinson's disease. These mechanisms remain latent in adulthood, and blocking Ca(v)1.3 Ca2+ channels in adult neurons induces a reversion to the juvenile form of pacemaking. Such blocking ('rejuvenation') protects these neurons in both in vitro and in vivo models of Parkinson's disease, pointing to a new strategy that could slow or stop the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558391     DOI: 10.1038/nature05865

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  362 in total

1.  Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice.

Authors:  Matthew W Bishop; Subhojit Chakraborty; Gillian A C Matthews; Antonios Dougalis; Nicholas W Wood; Richard Festenstein; Mark A Ungless
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

2.  Cav1.3 calcium channels are required for normal development of the auditory brainstem.

Authors:  Jan J Hirtz; Michael Boesen; Nadine Braun; Joachim W Deitmer; Florian Kramer; Christian Lohr; Britta Müller; Hans Gerd Nothwang; Jörg Striessnig; Stefan Löhrke; Eckhard Friauf
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

3.  The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.

Authors:  E Ilijic; J N Guzman; D J Surmeier
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

4.  Postnatal development and activation of L-type Ca2+ currents in locus ceruleus neurons: implications for a role for Ca2+ in central chemosensitivity.

Authors:  Ann N Imber; Robert W Putnam
Journal:  J Appl Physiol (1985)       Date:  2012-03-08

5.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

6.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

Review 7.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

8.  MPP(+) -dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons.

Authors:  A Masi; R Narducci; E Landucci; F Moroni; G Mannaioni
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

9.  CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease.

Authors:  Soosung Kang; Garry Cooper; Sara F Dunne; Brendon Dusel; Chi-Hao Luan; D James Surmeier; Richard B Silverman
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 10.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.